
Will Therapeutics Secures CAD $3.5 Million to Target Anorexia Biology
A CAD $3.5 million funding injection from the Government of Québec, facilitated by the research consortium CQDM, will accelerate the development of brain-targeted molecules. The three-year project, led by Dr. Salah El Mestikawy, aims to create the first pharmacological treatment for anorexia nervosa by addressing the neural circuitry behind compulsive behavior.
























